000 | 01611 a2200469 4500 | ||
---|---|---|---|
005 | 20250512075835.0 | ||
264 | 0 | _c19851009 | |
008 | 198510s 0 0 eng d | ||
022 | _a0098-1532 | ||
024 | 7 |
_a10.1002/mpo.2950130503 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aKoh, H K | |
245 | 0 | 0 |
_aAdjuvant therapy of cutaneous malignant melanoma: a critical review. _h[electronic resource] |
260 |
_bMedical and pediatric oncology _c1985 |
||
300 |
_a244-60 p. _bdigital |
||
500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't; Review | ||
650 | 0 | 4 |
_aBCG Vaccine _xadverse effects |
650 | 0 | 4 |
_aBacterial Vaccines _xtherapeutic use |
650 | 0 | 4 | _aCombined Modality Therapy |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 |
_aImmunotherapy _xmethods |
650 | 0 | 4 |
_aLevamisole _xtherapeutic use |
650 | 0 | 4 | _aLymph Node Excision |
650 | 0 | 4 |
_aMelanoma _ximmunology |
650 | 0 | 4 |
_aNeoplasm Metastasis _xprevention & control |
650 | 0 | 4 |
_aNeoplasm Recurrence, Local _xprevention & control |
650 | 0 | 4 | _aNeoplasm Staging |
650 | 0 | 4 | _aPrognosis |
650 | 0 | 4 |
_aPropionibacterium acnes _ximmunology |
650 | 0 | 4 | _aRandom Allocation |
650 | 0 | 4 | _aResearch Design |
650 | 0 | 4 | _aRisk |
650 | 0 | 4 |
_aSkin Neoplasms _ximmunology |
650 | 0 | 4 | _aTime Factors |
650 | 0 | 4 |
_aTransfer Factor _xtherapeutic use |
700 | 1 | _aSober, A J | |
700 | 1 | _aHarmon, D C | |
700 | 1 | _aLew, R A | |
700 | 1 | _aCarey, R W | |
773 | 0 |
_tMedical and pediatric oncology _gvol. 13 _gno. 5 _gp. 244-60 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1002/mpo.2950130503 _zAvailable from publisher's website |
999 |
_c3903507 _d3903507 |